BioSpace News Archive

Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference.

Zentalis® Pharmaceuticals, Inc. announced that Zentalis management will participate in several upcoming investor conferences.

Mersana Therapeutics, Inc. provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2023.

Editas Medicine, Inc., a clinical-stage genome editing company, reported financial results for the fourth quarter and full year 2023 and provided business updates.

Leading biotechnology company Pluri Inc. issued the following update from CEO and President, Yaky Yanay.

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) today announced that the first patient has been dosed in the randomized CheMo4METPANC Phase 2 combination clinical trial evaluating the company’s CXCR4 inhibitor motixafortide, the PD-1 inhibitor cemiplimab, and standard of care chemotherapies gemcitabine and nab-paclitaxel, versus gemcitabine and nab-paclitaxel alone, in first-line pancreatic cancer (PDAC).

Today, Ginkgo Bioworks announced the acquisition of Proof Diagnostics, an innovative life sciences tools, diagnostics and computational discovery company which uncovered genome engineering tools for both therapeutic and diagnostics applications.

Our 2023 performance showcases our unwavering commitment to ensuring people with severe diseases can live the life they like, as free as possible from challenges of disease, reaching more than 3.2 million patients globally with severe immunological and neurological conditions.

Lutris Pharma today announced that the U.S. Food and Drug Administration’s (FDA) Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to lead compound, LUT014.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences.